Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials. Viglietta V, Miller D, Bar-Or A, Phillips TJ, Arnold DL, Selmaj K, Kita M, Hutchinson M, Yang M, Zhang R, et al. Ann Clin Transl Neurol. 2015 Feb; 2(2):103-18. Epub 2014 Dec 04. PMID: 25750916. Abstract CommentRecommendBookmarkWatch